Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill shows promise against tough cancers in early trial

NCT ID NCT06395519

First seen Mar 27, 2026 · Last updated Jun 18, 2026 · Updated 16 times

Summary

This study is testing an experimental drug called ETX-19477 in people with advanced solid tumors (like breast, ovarian, or prostate cancer) that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors or slow their growth. About 120 adults will take part in this early-phase trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fred Hutchinson Cancer Center

    RECRUITING

    Seattle, Washington, 98109, United States

    Contact

  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact

  • Mayo Clinic

    RECRUITING

    Phoenix, Arizona, 85054, United States

    Contact

  • Mayo Clinic

    RECRUITING

    Jacksonville, Florida, 32224, United States

    Contact

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact

  • START Center for Cancer Care - Mountain Region

    RECRUITING

    Salt Lake City, Utah, 84112, United States

    Contact

  • Stefanie Spielman Comprehensive Breast Center

    RECRUITING

    Columbus, Ohio, 43212, United States

    Contact

  • Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

    Contact

  • University of Chicago Medical Center

    RECRUITING

    Chicago, Illinois, 60637, United States

    Contact

  • Virginia Cancer Specialists

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact

  • Yale University, Yale Cancer Center

    RECRUITING

    New Haven, Connecticut, 06510, United States

    Contact

Conditions

The condition(s) this trial relates to.

BRCA1-related cancer predisposition BRCA2-related cancer predisposition breast cancer breast neoplasm Carcinoma, Ovarian Epithelial castration-resistant prostate carcinoma colorectal cancer colorectal neoplasm endometrial cancer endometrium neoplasm estrogen-receptor positive breast cancer gastric cancer gastric neoplasm metastatic malignant neoplasm neoplasm ovarian cancer ovarian carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.